Back
Knight Therapeutics Vs. GeneDx Holdings Industry Stock Comparison
Sell
36
GUD.TO
Knight Therapeutics
Last Price:
$5.42
Seasonality Move:
-2.14%
Buy
80
WGS
GeneDx Holdings
Last Price:
$96.73
Seasonality Move:
50.4%
Sell
36
Knight Therapeutics (GUD.TO)
is a Sell
Is Knight Therapeutics a Buy, Sell or Hold?
-
The current Knight Therapeutics [GUD.TO] share price is $5.42. The Score for GUD.TO is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
GUD.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
GeneDx Holdings (WGS)
is a Buy
Is GeneDx Holdings a Buy, Sell or Hold?
-
The current GeneDx Holdings [WGS] share price is $96.57. The Score for WGS is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
-
WGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GUD.TO Stock Price Chart
What is Knight Therapeutics's stock price today?
-
The Knight Therapeutics share price today is $5.42Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GUD.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.
WGS Stock Price Chart
What is GeneDx Holdings's stock price today?
-
The GeneDx Holdings share price today is $96.57Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
GUD.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 58.51 | Buy |
Chaikin Money Flow: | 61565 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.22 - 5.38) | Buy |
Bollinger Bands (100): | (5.28 - 5.84) | Sell |
WGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.3 | Buy |
Relative Strength Index (14 RSI): | 73.61 | Buy |
Chaikin Money Flow: | 604773 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (72.61 - 85.19) | Buy |
Bollinger Bands (100): | (40.91 - 79.21) | Buy |
GUD.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.36 | Buy |
20-day SMA: | 5.28 | Buy |
50-day SMA: | 5.33 | Buy |
200-day SMA: | 5.63 | Sell |
8-day EMA: | 5.36 | Buy |
20-day EMA: | 5.32 | Buy |
50-day EMA: | 5.37 | Buy |
200-day EMA: | 5.5 | Sell |
WGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 84.19 | Buy |
20-day SMA: | 79.45 | Buy |
50-day SMA: | 77.26 | Buy |
200-day SMA: | 41.28 | Buy |
8-day EMA: | 87 | Buy |
20-day EMA: | 81.62 | Buy |
50-day EMA: | 74.47 | Buy |
200-day EMA: | 47.95 | Buy |
Knight Therapeutics Earnings Growth & GUD.TO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.16 per share.
GeneDx Holdings Earnings Growth & WGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.86 per share, and an increase next year of $0.92 per share.
Knight Therapeutics Technical Analysis
Dec 23 | Dec 24 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
23 | 24 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
GeneDx Holdings Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |